EspaƱol
Questions About Cancer? 1-800-4-CANCER
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Popular Resources

Fred Hutchinson/University of Washington Cancer Consortium
Comprehensive Cancer Center

Gary Gilliland, M.D., Ph.D.
President & Director

P.O. Box 19024, D1-060
Seattle, Washington 98109
SCCA - New Patients/Intake: (206) 288-1024
SCCA Main: (206) 288-7222
Toll Free: 1-800-804-8824

Visit Website

Fred Hutchinson/University of Washington Cancer Consortium
Seattle, Washington

The Fred Hutchinson/University of Washington Cancer Consortium is a research collaboration comprising Fred Hutchinson Cancer Research Center and its collaborators, the University of Washington, Seattle Children’s, and the Seattle Cancer Care Alliance (SCCA). Founded in 1972, Fred Hutch received its NCI comprehensive center designation in 1976, which was expanded to include the entire Consortium in 2003.

By bringing together over 500 faculty with research interests in basic, clinical and public health sciences related to cancer, the Consortium conducts research across many types of cancer to accelerate scientific progress. The faculty in the Consortium are organized into nine research programs: Biostatistics and Computational Biology; Cancer Basic Biology; Cancer Epidemiology, Prevention and Control; Gastrointestinal Cancer; Global Oncology; Hematologic Malignancies; Immunology and Vaccine Development; Prostate Cancer; and Women’s Cancer.

There are five scientific areas of special focus in which the Consortium is poised to make an impact: cancer immunotherapy; basic biology of cancer; population-based research; health care economics and outcomes research; and global oncology.
One focus of particular significance is Fred Hutch’s work on immunotherapy, starting with bone marrow transplantation. Consortium researchers are developing novel approaches to harness immunotherapy to treat leukemia and other cancers. The Consortium is expanding this work into treatment of more common solid tumors such as melanoma, breast, prostate, colon, kidney and ovarian cancer.

The Consortium has an active program of clinical trials, with more than 600 clinical studies active at any one time, investigating the safety and efficacy of new methods of diagnosis, treatment, preventive and supportive care.
Research-based outreach by the Consortium to underserved communities takes several forms. In the Asian American community, the Consortium focuses on community development and health education. A collaboration with New Mexico State University focuses on increasing minority engagement in cancer research. Fred Hutch’s collaboration with the Seattle Cancer Care Alliance emphasizes activities related to cancer prevention and survivorship.

* This profile was provided by the Fred Hutchinson/University of Washington Cancer Consortium.

  • Updated: January 15, 2015